Global Next Generation Interceptor Industry Research 2024-2034 Featuring Lockheed Martin, Northrop Grumman, RTX, Aerojet Rocketdyne, BAE, Thales, General Dynamics, SAAB, MBDA Konsgberg, Leonardo DRS
May 17, 2024 05:08 ET
|
Research and Markets
Dublin, May 17, 2024 (GLOBE NEWSWIRE) -- The "Next Generation Interceptor Market - Global and Regional Analysis: Focus on Application, End User, Range, Component, Deployment Method, and Country -...
Red Cross announces new field hospital in Rafah
May 16, 2024 10:02 ET
|
Canadian Red Cross / Croix-Rouge canadienne
OTTAWA, May 16, 2024 (GLOBE NEWSWIRE) -- In response to the overwhelming demand for health care in Gaza, the Canadian Red Cross, in collaboration with the International Committee of the Red Cross...
MoonLake Immunotherapeutics starts Phase 3 VELA program of the Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa
May 16, 2024 08:00 ET
|
MoonLake Immunotherapeutics AG
MoonLake Immunotherapeutics starts Phase 3 VELA program of the Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa VELA is the first Phase 3 program in hidradenitis...
Muscular Dystrophy Association Celebrates Historic Advancements in Accessible Air Travel as Congress Passes FAA Reauthorization
May 15, 2024 14:57 ET
|
Muscular Dystrophy Association
Washington, D.C., May 15, 2024 (GLOBE NEWSWIRE) -- Today, the Muscular Dystrophy Association (MDA) celebrates a landmark achievement in accessible air travel as Congress grants final passage to the...
AB Science annonce ses résultats financiers annuels arrêtés au 31 décembre 2023 et présente un point sur ses activités
May 15, 2024 14:16 ET
|
AB Science
COMMUNIQUE DE PRESSE AB SCIENCE PRÉSENTE SES RÉSULTATS FINANCIERS ANNUELS AU 31 DECEMBRE 2023 ET LES EVENEMENTS CLEFS DE LA PERIODE Développement clinique Poursuite des...
AB Science reports its revenues for the year 2023 and provides an update on its activities
May 15, 2024 14:16 ET
|
AB Science
PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL INFORMATION AS OF DECEMBER 31, 2023 AND THE KEY EVENTS OF THE PERIOD Clinical development Continuation of the conditional...
Calian annonce des résultats record au deuxième trimestre
May 14, 2024 18:17 ET
|
Calian Group Ltd.
(Tous les montants dans le communiqué sont en dollars canadiens.) OTTAWA, 14 mai 2024 (GLOBE NEWSWIRE) -- CalianMD Group Ltd. (TSX : CGY), une société de produits et services divers qui...
Calian Reports Record Results for the Second Quarter
May 14, 2024 18:17 ET
|
Calian Group Ltd.
Calian® Group Ltd. (TSX:CGY) released its results for the second quarter ended March 31, 2024.
PepGen Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
May 14, 2024 16:02 ET
|
PepGen Inc.
– CONNECT1-EDO51 trial preliminary data from 5mg/kg dose cohort expected mid-2024 – – FREEDOM1-DM1 trial preliminary data from at least 5mg/kg dose cohort expected second half 2024 – – Net...
Capricor Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 13, 2024 16:05 ET
|
Capricor Therapeutics
–Phase 3, HOPE-3 Trial (Cohort A) of CAP-1002 in Duchenne Muscular Dystrophy Fully Enrolled; On Track to Report Top-Line Data in Q4 2024– –Positive Type-B CMC FDA Meeting held in Q1; Company Aligned...